Tikhonova, L. G.; Serebryakova, E. S.; Maksikova, A. V., Journal of Organic Chemistry USSR (English Translation), 1981, vol. 17, p. 1244 - 1248
作者:Tikhonova, L. G.、Serebryakova, E. S.、Maksikova, A. V.、Chernysheva, G. V.、Vereshchagin, L. I.
DOI:——
日期:——
TSYPIN G. I.; TIMOFEEVA T. N.; MELNIKOV V. V.; GIDASPOV B. V., ZH. ORGAN. XIMII <ZORS-AE>, 1975, HO 7, 1395-1400
作者:TSYPIN G. I.、 TIMOFEEVA T. N.、 MELNIKOV V. V.、 GIDASPOV B. V.
DOI:——
日期:——
COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
申请人:MODERNATX, Inc.
公开号:US20170224844A1
公开(公告)日:2017-08-10
The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.
[EN] BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS<br/>[FR] MOLÉCULES BIFONCTIONNELLES À ACTIVITÉ DE RECRUTEMENT D'ANTICORPS ET D'INHIBITION D'ENTRÉE DIRIGÉES CONTRE LE VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
申请人:UNIV YALE
公开号:WO2011046946A2
公开(公告)日:2011-04-21
The present invention is directed to new bifunctional compounds and methods for treating HIV infections. The bifunctional small molecules, generally referred to as ARM-H' function through orthogonal pathways, by inhibiting the gp120-CD4 interaction, and by recruiting anti-DNP antibodies to gp120-expressing cells, thereby preventing cell infection and spread of HIV. It has been shown that ARM-H's bind to gp120 and gp-120 expressing cells competitively with CD4, thereby decreasing viral infectivity as shown by an MT-2 cell assay, the binding leading to formation of a ternary complex by recruiting anti-DNP antibodies to bind thereto, the antibodies present in the ternary complex promoting the complement-dependent destruction of the gp120-expressing cells. Compounds and methods are described herein.
Design, synthesis, anticancer and <i>in silico</i> assessment of 8-caffeinyl-triazolylmethoxy hybrid conjugates
Design, synthesis, anticancer, docking and in silico assessment for 8-caffeinyl-triazolylmethoxy hybrid conjugates are explained. These compounds have remarkable activities against malanoma and breast cancer cell lines.